What are Money-Magnet Moderna’s future plans? French Founding CEO explains here

16/11/2015 - 1 minute

Before the end of the mRNA conference in Berlin, I had to interview Stephane Bancel, the French founding CEO of Moderna…one of the biggest deals in Biotech today.

moderna_logoModerna is the mRNA therapies companies from Cambridge/Boston (US), most famous for having raised over 900 million dollars in VC money. I met Stephane one and a half years ago during our Labiotech Tour Boston, and this interview was a great opportunity to catch-up and ask how things have been moving forward since…

Moderna is the leader in mRNA Therapeutics, with pipelines which spanning fields to include rare disease, Oncology, ‘BioDefense’, chronic and infectious disease. Their impressive network of partners and research institutions (including Institut Pasteur) has granted them a strong foothold in the industry, which earlier this year raked in the highest VC investment rounds into a single Biotech ever.

moderna_mrna_stephan_bancel

Personal comment: It was also a great reminder of all my Boston memories and why it’s so much of a great city for Biotech.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member